BIG
EWTX icon

Brooklyn Investment Group’s Edgewise Therapeutics EWTX Stock Holding History

Brooklyn Investment Group’s Portfolio EWTX Stock Details EWTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$511K Buy
+16,221
New +$468K 0.02% 1007
2025
Q3 		– Sell
-1,314
Closed -$17.2K – 1325
2025
Q2 		$17.2K Buy
+1,314
New +$18.9K ﹤0.01% 1901

Other funds holding EWTX

O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.72B AUM 106.92% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

Brooklyn Investment Group's EWTX Position: Q1 2026 in Review

Brooklyn Investment Group opened a new position in Edgewise Therapeutics (EWTX) in Q1 2026: 16,221 shares worth $511K. The stake represents 0.02% of the portfolio and ranks #1007 among its holdings. This is a return to the name: Brooklyn Investment Group previously reported a position in EWTX as recently as Q2 2025.

Brooklyn Investment Group first reported a position in EWTX in Q2 2025 and has held it in 2 quarters since. 214 funds tracked by Wall St. Rank hold EWTX as of Q1 2026.

  • Brooklyn Investment Group held 16,221 shares of Edgewise Therapeutics worth $511K as of Q1 2026.
  • Edgewise Therapeutics was a new Brooklyn Investment Group position in Q1 2026.
  • Edgewise Therapeutics made up 0.02% of Brooklyn Investment Group's portfolio in Q1 2026, its #1007 holding.
  • Brooklyn Investment Group first reported a position in Edgewise Therapeutics in Q2 2025 and has held it in 2 quarters since.
  • 214 funds tracked by Wall St. Rank held Edgewise Therapeutics as of Q1 2026.

Based on Brooklyn Investment Group's 13F filing for Q1 2026, filed 29 Apr 2026.